Omeprazole

Active ingredient description

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Omeprazole
A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC01

Medicines

Omeprazole is the active ingredient of these drugs:

Drug
Countries

Australia

Poland

South Africa

Hong Kong

Italy

Italy

Germany

Spain

Spain

Tunisia

Poland

Ireland

Italy

South Africa

Spain

Hong Kong

Brazil

Hong Kong

Brazil

Cyprus Hong Kong

Estonia Hong Kong Lithuania Poland

Hong Kong

Hong Kong

Tunisia

Spain

South Africa

Hong Kong

Poland

Poland

Poland

Italy

Poland

Tunisia

Italy

Italy

Ireland

Italy

South Africa

Hong Kong

Hong Kong

Ireland

Hong Kong

Australia Austria Brazil Canada Cyprus

Netherlands

Hong Kong

Estonia Poland

Brazil

Tunisia

Italy

Australia

Cyprus

Italy

United Kingdom

France Tunisia

Italy

Brazil

Brazil

Hong Kong

Hong Kong

Brazil

South Africa

Spain

Singapore

Cyprus

Lithuania

Singapore

Spain

Germany

Poland

Austria

Netherlands

Hong Kong

Hong Kong

Lithuania

Estonia

Hong Kong

Spain

Brazil

Singapore

South Africa

Singapore

Australia

Austria

Brazil

Italy

Brazil

Spain

Hong Kong Singapore

Finland

South Africa

Hong Kong New Zealand Singapore Tunisia

Hong Kong Singapore

Singapore

South Africa

South Africa

Hong Kong

Hong Kong

Hong Kong

Estonia Italy

Brazil

Cyprus

Tunisia

Brazil

Poland

Australia

Spain

Ireland Netherlands New Zealand

Australia

Cyprus Singapore

Spain

Poland

Brazil

Poland

United States

Australia New Zealand Singapore South Africa

Singapore

Poland

Singapore

Italy

Singapore

Hong Kong

United Kingdom

Singapore

Hong Kong

Cyprus

Lithuania

Tunisia

Singapore

Poland

Singapore

Brazil

South Africa

Spain

Spain

Italy

Estonia Lithuania Poland

Lithuania

Poland

Hong Kong

Hong Kong

Estonia

Hong Kong Singapore

Hong Kong

Singapore

France

Omeprazole is also found within below combination drugs:

ARTHROCOMB , CECLOVA , DICLODUO COMBI , DICLOPRAM , DIOMPRAZ , OMEPRAMIX , PROFENID PROTECT , TALICIA , YOSPRALA , ZEGERID

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Structured Product Labeling (SPL/PLR)
US

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

KG60484QX9 - OMEPRAZOLE

CAS registry number

73590-58-6 - omeprazole

95510-70-6 - Omeprazole sodium

SNOMED-CT

387137007 - Omeprazole (substance)